13.52 USD
+0.74 (+5.79%)
13.66 USD
+0.14 (+1.04%)
ChartMill assigns a Buy % Consensus number of 80% to VOR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 41.41. This target is 206.3% above the current price.
VOR was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VOR.
In the previous month the buy percentage consensus was at a similar level.
VOR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-09 | Citigroup | Initiate | Buy |
| 2025-12-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-17 | TD Cowen | Initiate | Buy |
| 2025-12-09 | JP Morgan | Initiate | Overweight |
| 2025-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-15 | Baird | Upgrade | Neutral -> Outperform |
| 2025-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-30 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-06-27 | Baird | Maintains | Neutral -> Neutral |
| 2025-06-26 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-05-09 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-05-09 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-03-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2025-03-21 | Stifel | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-06 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-13 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-13 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-21 | Stifel | Maintains | Buy -> Buy |
VOR BIOPHARMA INC / VOR FAQ
Can you provide the average price target for VOR BIOPHARMA INC stock?
9 analysts have analysed VOR and the average price target is 41.41 USD. This implies a price increase of 206.3% is expected in the next year compared to the current price of 13.52.
What is the consensus rating for VOR stock?
The consensus rating for VOR BIOPHARMA INC (VOR) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.